Dashboard
Program Home
WTC 2025 Website
Login
Dashboard
Program Home
WTC 2025 Website
Login
Kidney Rejection
Monday August 04, 2025 - 16:30 to 17:45
Room: 25
26.3 Tocilizumab Stabilizes Kidney Function and Reduce DSA in Kidney Transplant Recipients with Chronic Active Antibody-Mediated Rejection
Log in to add to favorites
Add Personal Notes
Johan Noble, France
Presentations by Johan Noble
Mon-04 from 16:30 - 17:45 in room 25
Kidney Rejection
Tocilizumab Stabilizes Kidney Function and Reduce DSA in Kidney Transplant Recipients with Chronic Active Antibody-Mediated Rejection
Email:
info@wtc2025.org
514-874-1717
